Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension
-
Published:2020-09
Issue:9
Volume:26
Page:1364-1374
-
ISSN:1078-8956
-
Container-title:Nature Medicine
-
language:en
-
Short-container-title:Nat Med
Author:
Liu Xiaoxuan, Cruz Rivera Samantha, Moher DavidORCID, Calvert Melanie J.ORCID, Denniston Alastair K.ORCID, Chan An-Wen, Darzi Ara, Holmes Christopher, Yau Christopher, Ashrafian Hutan, Deeks Jonathan J., Ferrante di Ruffano Lavinia, Faes Livia, Keane Pearse A., Vollmer Sebastian J., Lee Aaron Y., Jonas Adrian, Esteva Andre, Beam Andrew L., Chan An-Wen, Panico Maria Beatrice, Lee Cecilia S., Haug Charlotte, Kelly Christopher J., Yau Christopher, Mulrow Cynthia, Espinoza Cyrus, Fletcher John, Paltoo Dina, Manna Elaine, Price Gary, Collins Gary S., Harvey Hugh, Matcham James, Monteiro Joao, ElZarrad M. Khair, Ferrante di Ruffano Lavinia, Oakden-Rayner Luke, McCradden Melissa, Keane Pearse A., Savage Richard, Golub Robert, Sarkar Rupa, Rowley Samuel, , ,
Abstract
AbstractThe CONSORT 2010 statement provides minimum guidelines for reporting randomized trials. Its widespread use has been instrumental in ensuring transparency in the evaluation of new interventions. More recently, there has been a growing recognition that interventions involving artificial intelligence (AI) need to undergo rigorous, prospective evaluation to demonstrate impact on health outcomes. The CONSORT-AI (Consolidated Standards of Reporting Trials–Artificial Intelligence) extension is a new reporting guideline for clinical trials evaluating interventions with an AI component. It was developed in parallel with its companion statement for clinical trial protocols: SPIRIT-AI (Standard Protocol Items: Recommendations for Interventional Trials–Artificial Intelligence). Both guidelines were developed through a staged consensus process involving literature review and expert consultation to generate 29 candidate items, which were assessed by an international multi-stakeholder group in a two-stage Delphi survey (103 stakeholders), agreed upon in a two-day consensus meeting (31 stakeholders) and refined through a checklist pilot (34 participants). The CONSORT-AI extension includes 14 new items that were considered sufficiently important for AI interventions that they should be routinely reported in addition to the core CONSORT 2010 items. CONSORT-AI recommends that investigators provide clear descriptions of the AI intervention, including instructions and skills required for use, the setting in which the AI intervention is integrated, the handling of inputs and outputs of the AI intervention, the human–AI interaction and provision of an analysis of error cases. CONSORT-AI will help promote transparency and completeness in reporting clinical trials for AI interventions. It will assist editors and peer reviewers, as well as the general readership, to understand, interpret and critically appraise the quality of clinical trial design and risk of bias in the reported outcomes.
Funder
Wellcome Trust Alan Turing Institute
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference63 articles.
1. Sibbald, B. & Roland, M. Understanding controlled trials. Why are randomised controlled trials important? Br. Med. J. 316, 201 (1998). 2. Peto, R., Collins, R. & Gray, R. Large-scale randomized evidence: large, simple trials and overviews of trials. J. Clin. Epidemiol. 48, 23–40 (1995). 3. Jüni, P., Altman, D. G. & Egger, M. Systematic reviews in health care: assessing the quality of controlled clinical trials. Br. Med. J. 323, 42–46 (2001). 4. Schulz, K. F., Chalmers, I., Hayes, R. J. & Altman, D. G. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. J. Am. Med. Assoc. 273, 408–412 (1995). 5. Moher, D. et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Br. Med. J. 340, c869 (2010).
Cited by
353 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|